- Home
- CCD vs DNA Comparison
CCD vs DNA Comparison
Compare CCD & DNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CCD
- DNA
- Stock Information
- Founded
- CCD 2014
- DNA 2008
- Country
- CCD United States
- DNA United States
- Employees
- CCD N/A
- DNA N/A
- Industry
- CCD Trusts Except Educational Religious and Charitable
- DNA Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- CCD Finance
- DNA Health Care
- Exchange
- CCD Nasdaq
- DNA Nasdaq
- Market Cap
- CCD 533.8M
- DNA 658.5M
- IPO Year
- CCD N/A
- DNA N/A
- Fundamental
- Price
- CCD $20.31
- DNA $9.42
- Analyst Decision
- CCD
- DNA Sell
- Analyst Count
- CCD 0
- DNA 3
- Target Price
- CCD N/A
- DNA $9.67
- AVG Volume (30 Days)
- CCD 96.1K
- DNA 1.6M
- Earning Date
- CCD 01-01-0001
- DNA 08-07-2025
- Dividend Yield
- CCD 10.61%
- DNA N/A
- EPS Growth
- CCD N/A
- DNA N/A
- EPS
- CCD N/A
- DNA N/A
- Revenue
- CCD N/A
- DNA $237,417,000.00
- Revenue This Year
- CCD N/A
- DNA N/A
- Revenue Next Year
- CCD N/A
- DNA $15.91
- P/E Ratio
- CCD N/A
- DNA N/A
- Revenue Growth
- CCD N/A
- DNA 13.76
- 52 Week Low
- CCD $16.93
- DNA $5.00
- 52 Week High
- CCD $24.68
- DNA $16.85
- Technical
- Relative Strength Index (RSI)
- CCD 48.82
- DNA 51.44
- Support Level
- CCD $20.18
- DNA $9.75
- Resistance Level
- CCD $20.60
- DNA $13.33
- Average True Range (ATR)
- CCD 0.17
- DNA 0.87
- MACD
- CCD 0.08
- DNA -0.18
- Stochastic Oscillator
- CCD 67.28
- DNA 28.59
About CCD Calamos Dynamic Convertible & Income Fund
Calamos Dynamic Convertible and Income Fund operates as a diversified, closed-end management investment company. The fund's investment objective is to provide total return through a combination of current income and capital appreciation. It predominantly invests in a portfolio of convertible securities, investment grade and below investment grade bonds, loans, equity-linked notes, and floating rate securities.
About DNA Ginkgo Bioworks Holdings Inc.
Ginkgo Bioworks Holdings Inc is the platform for cell programming, providing flexible, end-to-end services that solve challenges for organizations across diverse markets, from food and agriculture to pharmaceuticals to industrial and specialty chemicals. The Company reorganized its operations into two operating and reportable segments: Cell Engineering: where company provide biological R&D services for customers across a range of industries and Biosecurity: where it provide services to government and commercial customers to identify, monitor, prevent, mitigate, and ultimately protect humanity from biological threats. The maximum of revenue is from Cell Engineering Segment.